Capricor Therapeutics | CAPR - Sales Revenues


Capricor Therapeutics reported $11.13M in Sales Revenues for its fiscal quarter ending in December of 2024.





Sales Change Date
Alterity Therapeutics Limited AUD 596.04K 584.66K Dec/2025
Bioline Rx USD 427K 123K Sep/2025
Capricor Therapeutics USD 11.13M 8.87M Dec/2024
Cipla INR 65.41B 9.77B Mar/2026
Cytokinetics USD 19.35M 1.59M Mar/2026
Geron USD 51.84M 3.82M Mar/2026
Grifols EUR 2B 306.7M Mar/2026
J&J USD 24.1B 500M Mar/2026
Plus Therapeutics USD 1.37M 30K Dec/2025
Prothena USD 51.08M 51.06M Mar/2026
PTC Therapeutics USD 273M 108.3M Mar/2026
Sarepta Therapeutics USD 730.8M 287.9M Mar/2026